CHU de Bordeaux, Service de Maladies Coronaires et Vasculaires, F-33600 Pessac, France.
CHU de Bordeaux, Service de Neurologie, Hopital Pellegrin, Rue de la Pelouse de Douet, Bordeaux, 33076, France.
J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107290. doi: 10.1016/j.jstrokecerebrovasdis.2023.107290. Epub 2023 Aug 9.
Whether and how atherosclerotic ischemic stroke patients should be investigated for asymptomatic coronary artery disease (CAD) is controversial. Our aim was to carry out a prospective observational study to determine the frequency and predictors of functionally significant coronary stenosis in these patients as well as the predictors of major adverse cardiovascular events (MACE) during post-stroke follow-up.
From January 2014 to June 2018, patients with atherosclerotic ischemic stroke were referred from the stroke unit to our cardiovascular department 3+/- 1 months after the acute event where they benefited from evaluation of cardiovascular risk factors, vascular and myocardial disease. Main outcome was defined as the prevalence of myocardial ischemia defined by perfusion stress echography 3 months after stroke. Secondary outcome (MACE) was defined as the incidence of stroke, transient ischemic attack (TIA), acute coronary syndrome, cardiovascular (CV) death or coronary or peripheral revascularization during a 3 year follow-up.
Three hundred and twenty five patients (92% of strokes and 8% TIA) were included and median follow-up was 1075 days. At 3 months post-stroke, myocardial ischemia was found in 17 patients (5.2%). During the 3 year follow-up, 11 MACE occurred (3.4%, all in the non-ischemic group) of which 6 were recurrent strokes. In multivariate analysis, myocardial ischemia was significantly associated with the number of atheromatous vascular beds (OR 4.3; 95% CI, 1.7 to 10.6) and ECG signs of necrosis (OR 6.5; 95% CI, 1.9 to 21.9). MACE were also associated with ECG signs of necrosis (OR 3.5; 95% CI, 1.3 to 9.1), and unrelated to myocardial ischemia.
Myocardial ischemia and CV events were infrequent and both strongly associated with ECG signs of necrosis, suggesting a low yield of stress tests and the potential for a more straightforward algorithm in the choice of patients eligible to coronary angiogram or other coronary imaging in post-stroke setting.
对于动脉粥样硬化性缺血性脑卒中患者是否以及如何进行无症状性冠状动脉疾病(CAD)的检查存在争议。我们的目的是进行一项前瞻性观察研究,以确定这些患者中功能性显著冠状动脉狭窄的频率和预测因素,以及在卒中后随访期间主要不良心血管事件(MACE)的预测因素。
从 2014 年 1 月至 2018 年 6 月,从卒中病房转介了 325 名动脉粥样硬化性缺血性脑卒中患者到我们的心血管科,他们在急性事件发生后 3+/-1 个月接受了心血管危险因素、血管和心肌疾病的评估。主要结局定义为卒中后 3 个月时通过灌注应激超声心动图定义的心肌缺血的发生率。次要结局(MACE)定义为 3 年内卒中、短暂性脑缺血发作(TIA)、急性冠状动脉综合征、心血管(CV)死亡或冠状动脉或外周血运重建的发生率。
325 名患者(92%的卒中和 8%的 TIA)被纳入,中位随访时间为 1075 天。在卒中后 3 个月时,17 名患者(5.2%)出现心肌缺血。在 3 年的随访期间,发生了 11 次 MACE(3.4%,均发生在非缺血组),其中 6 次是复发性卒中。在多变量分析中,心肌缺血与动脉粥样硬化性血管床的数量显著相关(OR 4.3;95%CI,1.7 至 10.6)和心电图坏死征象(OR 6.5;95%CI,1.9 至 21.9)。MACE 也与心电图坏死征象相关(OR 3.5;95%CI,1.3 至 9.1),与心肌缺血无关。
心肌缺血和心血管事件发生率较低,均与心电图坏死征象强烈相关,提示应激试验的检出率较低,在选择适合接受冠状动脉造影或其他冠状动脉成像的患者方面,可能需要一种更直接的算法。